| First Author | Milman Krentsis I | Year | 2024 |
| Journal | Sci Adv | Volume | 10 |
| Issue | 34 | Pages | eadk2524 |
| PubMed ID | 39178253 | Mgi Jnum | J:353845 |
| Mgi Id | MGI:7713982 | Doi | 10.1126/sciadv.adk2524 |
| Citation | Milman Krentsis I, et al. (2024) Lung cell transplantation for pulmonary fibrosis. Sci Adv 10(34):eadk2524 |
| abstractText | Idiopathic pulmonary fibrosis is a major cause of death with few treatment options. Here, we demonstrate the therapeutic efficacy for lung fibrosis of adult lung cell transplantation using a single-cell suspension of the entire lung in two distinct mouse systems: bleomycin treatment and mice lacking telomeric repeat-binding factor 1 expression in alveolar type 2 (AT2) cells (SPC-Cre TRF1(fl/fl)), spontaneously developing fibrosis. In both models, the progression of fibrosis was associated with reduced levels of host lung progenitors, enabling engraftment of donor progenitors without any additional conditioning, in contrast to our previous studies. Two months after transplantation, engrafted progenitors expanded to form numerous donor-derived patches comprising AT1 and AT2 alveolar cells, as well as donor-derived mesenchymal and endothelial cells. This lung chimerism was associated with attenuation of fibrosis, as demonstrated histologically, biochemically, by computed tomography imaging, and by lung function measurements. Our study provides a strong rationale for the treatment of lung fibrosis using lung cell transplantation. |
